Shandong Boyuan Pharmaceutical &Chemical Co.,Ltd(301617)
Search documents
博苑股份11月17日获融资买入2565.73万元,融资余额1.69亿元
Xin Lang Cai Jing· 2025-11-18 01:43
Core Viewpoint - On November 17, 2023, Boyuan Co., Ltd. experienced a decline of 3.80% in stock price, with a trading volume of 299 million yuan, indicating potential market concerns regarding the company's performance and investor sentiment [1]. Financing Summary - On the same day, Boyuan Co., Ltd. had a financing buy-in amount of 25.66 million yuan and a financing repayment of 35.66 million yuan, resulting in a net financing outflow of 9.99 million yuan [1]. - As of November 17, the total financing and securities lending balance for Boyuan Co., Ltd. was 169 million yuan, which represents 5.56% of its circulating market value [1]. - There were no shares sold or repaid in the securities lending segment on November 17, with a remaining balance of 0 yuan [1]. Company Overview - Boyuan Co., Ltd., established on August 6, 2008, is located in Shouguang City, Shandong Province, and specializes in the research, production, and sales of fine chemicals, including organic and inorganic iodides, precious metal catalysts, luminescent materials, and hexamethyldisilazane [2]. - The company's revenue composition includes iodides (74.56%), specialty functional chemicals (12.79%), trading business (9.94%), and others (2.72%) [2]. - For the period from January to September 2025, Boyuan Co., Ltd. reported a revenue of 1.073 billion yuan, reflecting a year-on-year growth of 6.60%, while the net profit attributable to shareholders decreased by 22.53% to 132 million yuan [2]. Shareholder Information - As of November 10, 2025, Boyuan Co., Ltd. had 11,900 shareholders, a decrease of 12.88% from the previous period, with an average of 2,813 circulating shares per shareholder, an increase of 14.78% [2]. - The company has distributed a total of 88.41 million yuan in dividends since its A-share listing [3]. - Notable new institutional shareholders include Zhonghang New Start Flexible Allocation Mixed A, holding 1.3456 million shares, and several other funds that have recently entered the shareholder list [3].
博苑股份股价涨5.22%,中航基金旗下1只基金位居十大流通股东,持有134.56万股浮盈赚取623.04万元
Xin Lang Cai Jing· 2025-11-14 03:00
Core Viewpoint - The stock price of Boyuan Co., Ltd. has increased by 5.22% on November 14, reaching 93.30 CNY per share, with a total market capitalization of 12.469 billion CNY, indicating a continuous upward trend over the past three days with a cumulative increase of 5.45% [1] Company Overview - Boyuan Co., Ltd. is located in Shouguang City, Shandong Province, and was established on August 6, 2008. The company specializes in the research, production, and sales of fine chemicals, including organic iodides, inorganic iodides, precious metal catalysts, luminescent materials, and hexamethyldisilazane. It also engages in the recycling of iodine and precious metal materials [1] - The main revenue composition of Boyuan Co., Ltd. includes iodides (74.56%), specialty functional chemicals (12.79%), trading business (9.94%), and others (2.72%) [1] Shareholder Information - Among the top ten circulating shareholders of Boyuan Co., Ltd., a fund under AVIC Fund ranks as a significant holder. The AVIC New Start Flexible Allocation Mixed A Fund (005537) entered the top ten shareholders in the third quarter, holding 1.3456 million shares, which accounts for 4.03% of the circulating shares. The estimated floating profit today is approximately 6.2304 million CNY [2] - During the three-day increase, the floating profit earned was 616.31 thousand CNY [2] Fund Manager Profile - The fund manager of AVIC New Start Flexible Allocation Mixed A Fund (005537) is Han Hao, who has been in the position for 7 years and 338 days. The total asset size of the fund is 15.589 billion CNY, with the best fund return during his tenure being 205.01% and the worst being -18.95% [3]
博苑股份11月12日获融资买入2358.61万元,融资余额1.75亿元
Xin Lang Cai Jing· 2025-11-13 01:40
Core Insights - On November 12, Boyuan Co., Ltd. saw a stock increase of 1.35% with a trading volume of 211 million yuan [1] - The company reported a net financing purchase of 7.72 million yuan on the same day, with a total financing balance of 175 million yuan, accounting for 6.06% of its market capitalization [1][2] Company Overview - Boyuan Co., Ltd. is located in Shouguang City, Shandong Province, and was established on August 6, 2008, with a planned listing date of December 11, 2024 [2] - The company specializes in the research, production, and sales of fine chemicals, including organic iodides, inorganic iodides, precious metal catalysts, luminescent materials, and hexamethyldisilazane [2] - The revenue composition includes iodides (74.56%), specialty functional chemicals (12.79%), trading business (9.94%), and others (2.72%) [2] Financial Performance - For the period from January to September 2025, Boyuan Co., Ltd. achieved a revenue of 1.073 billion yuan, representing a year-on-year growth of 6.60% [2] - The net profit attributable to shareholders was 132 million yuan, showing a year-on-year decrease of 22.53% [2] Shareholder Information - As of November 10, 2025, the number of shareholders for Boyuan Co., Ltd. was 11,900, a decrease of 12.88% from the previous period [2] - The average circulating shares per person increased by 14.78% to 2,813 shares [2] - The company has distributed a total of 88.408 million yuan in dividends since its A-share listing [3] Institutional Holdings - As of September 30, 2025, several new institutional shareholders have entered, including: - China Aviation New Start Flexible Allocation Mixed A (005537) as the second-largest shareholder with 1.3456 million shares [3] - Hong Kong Central Clearing Limited as the third-largest shareholder with 964,400 shares [3] - Other new shareholders include Yongying New Materials and Penghua Huizhi [3]
博苑股份:截至2025年11月10日股东总户数为11873户
Zheng Quan Ri Bao· 2025-11-12 10:15
Core Insights - The company reported that as of November 10, 2025, the total number of shareholders is 11,873 [2] Summary by Category - **Shareholder Information** - The total number of shareholders for the company is 11,873 as of the specified date [2]
博苑股份:碘甲烷产品产能为200吨/年
Zheng Quan Ri Bao Wang· 2025-11-12 10:14
Group 1 - The core point of the article is that Boyuan Co., Ltd. (301617) has confirmed its iodine methyl product capacity to be 200 tons per year [1]
博苑股份:目前公司暂无直接应用于半导体领域的产品实现量产
Zheng Quan Ri Bao Wang· 2025-11-12 10:14
Group 1 - The core viewpoint of the article is that Boyuan Co., Ltd. has achieved large-scale sales of electronic-grade potassium iodide, primarily used in the polarizer industry [1] - The company currently does not have any products in mass production for direct application in the semiconductor field [1]
博苑股份:主要产品为精细化学品
Zheng Quan Ri Bao Zhi Sheng· 2025-11-12 10:10
Core Viewpoint - The company, Boyuan Co., primarily produces fine chemicals that are widely used in various sectors including pharmaceuticals, chemicals, optoelectronic materials, feed, and food [1] Group 1 - The main products of the company are fine chemicals [1] - The applications of the products span across multiple industries [1]
博苑股份:公司碘化锂产品的合作方相关信息属于商业秘密
Zheng Quan Ri Bao Wang· 2025-11-12 10:10
Group 1 - The company stated that information regarding its lithium iodide product partners is considered a trade secret and cannot be disclosed publicly [1] - Product pricing is adjusted based on market supply and demand factors, following industry practices [1]
博苑股份最新股东户数环比下降12.88%
Zheng Quan Shi Bao Wang· 2025-11-12 09:05
Core Viewpoint - 博苑股份 has seen a significant decrease in the number of shareholders, indicating a potential shift in investor sentiment and market dynamics [1] Shareholder Information - As of November 10, the number of shareholders for 博苑股份 was 11,873, a decrease of 1,755 from the previous period (October 31), representing a decline of 12.88% [1] Stock Performance - The closing price of 博苑股份 on the reporting date was 86.25 yuan, reflecting an increase of 1.35%. However, since the beginning of the current concentration period, the stock price has cumulatively decreased by 5.93%, with 4 days of increases and 4 days of decreases [1] Margin Trading Data - The latest margin trading balance for 博苑股份 as of November 11 was 167 million yuan, with the financing balance also at 167 million yuan. During the current concentration period, the financing balance has decreased by 34.0651 million yuan, a decline of 16.95% [1] Financial Performance - According to the third-quarter report, 博苑股份 achieved a total operating revenue of 1.073 billion yuan in the first three quarters, representing a year-on-year growth of 6.60%. However, net profit was 132 million yuan, showing a year-on-year decline of 22.41%. The basic earnings per share were 0.9912 yuan, and the weighted average return on equity was 7.93% [1]
博苑股份:接受富国基金等投资者调研
Mei Ri Jing Ji Xin Wen· 2025-11-12 08:59
Group 1 - The core viewpoint of the news is that Boyuan Co., Ltd. (SZ 301617) is actively engaging with investors, indicating a focus on transparency and communication regarding its business operations [1] - Boyuan Co., Ltd. will participate in an investor research meeting on November 12, 2025, with key executives including the Executive Vice President, Secretary of the Board, Chief Financial Officer, and Securities Affairs Representative present to address investor inquiries [1] - As of the latest report, Boyuan Co., Ltd. has a market capitalization of 11.5 billion yuan [3] Group 2 - For the year 2024, Boyuan Co., Ltd. reports that its revenue composition is entirely from the chemical industry, indicating a focused business model [2]